Essex Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Buy
7,814
+90
+1% +$12.6K 0.06% 267
2025
Q4
$948K Buy
7,724
+71
+0.9% +$8.63K 0.05% 295
2025
Q3
$849K Buy
7,653
+431
+6% +$49K 0.05% 308
2025
Q2
$801K Buy
7,222
+1,162
+19% +$124K 0.05% 307
2025
Q1
$679K Buy
6,060
+153
+3% +$15.8K 0.05% 313
2024
Q4
$546K Sell
5,907
-761
-11% -$68.5K 0.04% 360
2024
Q3
$588K Buy
6,668
+2,813
+73% +$215K 0.04% 346
2024
Q2
$291K Buy
3,855
+513
+15% +$34.2K 0.02% 488
2024
Q1
$245K Sell
3,342
-838
-20% -$64.4K 0.02% 465
2023
Q4
$339K Sell
4,180
-44
-1% -$3.42K 0.04% 372
2023
Q3
$317K Sell
4,224
-567
-12% -$43.6K 0.04% 362
2023
Q2
$369K Sell
4,791
-675
-12% -$53.8K 0.04% 329
2023
Q1
$454K Sell
5,466
-172
-3% -$14.2K 0.05% 308
2022
Q4
$484K Buy
5,638
+1,717
+44% +$136K 0.05% 280
2022
Q3
$242K Sell
3,921
-251
-6% -$15.8K 0.03% 387
2022
Q2
$258K Sell
4,172
-774
-16% -$47.9K 0.03% 395
2022
Q1
$294K Sell
4,946
-3,141
-39% -$201K 0.03% 380
2021
Q4
$587K Buy
8,087
+277
+4% +$19.1K 0.06% 259
2021
Q3
$546K Buy
7,810
+141
+2% +$9.91K 0.06% 256
2021
Q2
$496K Hold
7,669
0.07% 237
2021
Q1
$496K Sell
7,669
-1,112
-13% -$71.7K 0.09% 196
2020
Q4
$512K Sell
8,781
-1,117
-11% -$67.4K 0.1% 184
2020
Q3
$625K Sell
9,898
-1,235
-11% -$85.6K 0.15% 132
2020
Q2
$857K Sell
11,133
-1,591
-13% -$122K 0.26% 94
2020
Q1
$951K Hold
12,724
0.34% 79
2019
Q4
$827K Sell
12,724
-871
-6% -$56.7K 0.23% 100
2019
Q3
$862K Sell
13,595
-274
-2% -$17.9K 0.28% 89
2019
Q2
$937K Sell
13,869
-59
-0.4% -$3.88K 0.28% 85
2019
Q1
$905K Sell
13,928
-1,215
-8% -$80.8K 0.27% 83
2018
Q4
$947K Sell
15,143
-2,099
-12% -$147K 0.29% 82
2018
Q3
$1.33M Sell
17,242
-1,456
-8% -$110K 0.29% 82
2018
Q2
$1.32M Sell
18,698
-776
-4% -$54.8K 0.32% 77
2018
Q1
$1.47M Sell
19,474
-349
-2% -$27.7K 0.29% 98
2017
Q4
$1.42M Sell
19,823
-2,075
-9% -$158K 0.34% 75
2017
Q3
$1.77M Sell
21,898
-205
-0.9% -$15.7K 0.44% 60
2017
Q2
$1.56M Sell
22,103
-2,417
-10% -$161K 0.33% 77
2017
Q1
$1.67M Sell
24,520
-3,120
-11% -$219K 0.38% 65
2016
Q4
$1.98M Buy
27,640
+636
+2% +$47.3K 0.42% 63
2016
Q3
$2.13M Sell
27,004
-4,160
-13% -$338K 0.51% 52
2016
Q2
$2.6M Sell
31,164
-1,458
-4% -$129K 0.63% 42
2016
Q1
$3M Sell
32,622
-4,672
-13% -$421K 0.74% 37
2015
Q4
$3.77M Buy
37,294
+2,633
+8% +$274K 0.91% 24
2015
Q3
$3.4M Buy
34,661
+3,047
+10% +$338K 0.88% 28
2015
Q2
$3.7M Buy
31,614
+1,395
+5% +$152K 0.95% 20
2015
Q1
$2.96M Buy
30,219
+4,492
+17% +$456K 0.76% 36
2014
Q4
$2.42M Buy
25,727
+5,127
+25% +$530K 0.63% 41
2014
Q3
$2.19M Buy
20,600
+3,400
+20% +$333K 0.66% 36
2014
Q2
$1.43M Buy
17,200
+10,082
+142% +$785K 0.43% 57
2014
Q1
$504K Buy
7,118
+3,375
+90% +$265K 0.16% 141
2013
Q4
$281K Sell
3,743
-805
-18% -$56.1K 0.1% 212
2013
Q3
$286 Buy
4,548
+100
+2% +$5.98K 0.09% 197
2013
Q2
$228K Buy
+4,448
New +$232K 0.08% 226

Other funds holding GILD

Essex Financial Services's GILD Position: Q1 2026 in Review

Essex Financial Services increased its Gilead Sciences (GILD) stake by 1.2% in Q1 2026, buying an estimated $12.6K and bringing the position to 7,814 shares worth $1.09M. The position accounts for 0.06% of the portfolio, ranked #267.

Essex Financial Services first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.77M in Q4 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Essex Financial Services held 7,814 shares of Gilead Sciences worth $1.09M as of Q1 2026.
  • Essex Financial Services bought 90 Gilead Sciences shares in Q1 2026, an estimated $12.6K.
  • Gilead Sciences made up 0.06% of Essex Financial Services's portfolio in Q1 2026, its #267 holding.
  • Essex Financial Services first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Essex Financial Services's Gilead Sciences position peaked at $3.77M in Q4 2015.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.